The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial

BACKGROUND: In the anesthesia management of percutaneous liver tumor ablation, the requirement of analgesia is very strict. Currently, intravenous anesthesia is commonly used, such as remifentanil combined with sedative drugs. However, the pain relief is not instantaneous after increasing the dosage...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yanbing, Zhang, Jianxing, Wang, Huanwei, Gu, Yangkui, Ouyang, Handong, Huang, Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279786/
https://www.ncbi.nlm.nih.gov/pubmed/35845514
http://dx.doi.org/10.21037/atm-22-2756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279786/
https://www.ncbi.nlm.nih.gov/pubmed/35845514
http://dx.doi.org/10.21037/atm-22-2756

Ejemplares similares